Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1

Abstract Previous studies examining the role of the histone deacetylase Hdac3 within myeloid cells demonstrated that Hdac3 promotes M2 activation and tissue healing in inflammatory conditions. Since myeloid lineage cells are required for proper bone formation and regeneration, in this study we exami...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David H. H. Molstad, Elizabeth Zars, Andrew Norton, Kim C. Mansky, Jennifer J. Westendorf, Elizabeth W. Bradley
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/75c8d6bcd4f746f8a282c844bfc8dcbf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:75c8d6bcd4f746f8a282c844bfc8dcbf
record_format dspace
spelling oai:doaj.org-article:75c8d6bcd4f746f8a282c844bfc8dcbf2021-12-02T11:43:51ZHdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa110.1038/s41598-020-78364-52045-2322https://doaj.org/article/75c8d6bcd4f746f8a282c844bfc8dcbf2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78364-5https://doaj.org/toc/2045-2322Abstract Previous studies examining the role of the histone deacetylase Hdac3 within myeloid cells demonstrated that Hdac3 promotes M2 activation and tissue healing in inflammatory conditions. Since myeloid lineage cells are required for proper bone formation and regeneration, in this study we examined the functions of Hdac3 during bone healing. Conditional deletion of Hdac3 within myeloid progenitors accelerates healing of cortical bone defects. Moreover, reduced osteoclast numbers within the defect site are correlated with Hdac3 suppression. Ex vivo osteoclastogenesis assays further demonstrate that Hdac3 deficiency limits osteoclastogenesis, the number of nuclei per cell and bone resorption, suggesting a defect in cell fusion. High throughput RNA sequencing identified the transmembrane protein Pmepa1 as a differentially expressed gene within osteoclast progenitor cells. Knockdown of Pmepa1 partially restores defects in osteoclastogenesis induced by Hdac3 deficiency. These results show that Hdac3 is required for optimal bone healing and osteoclast fusion, potentially via its regulation of Pmepa1 expression.David H. H. MolstadElizabeth ZarsAndrew NortonKim C. ManskyJennifer J. WestendorfElizabeth W. BradleyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
David H. H. Molstad
Elizabeth Zars
Andrew Norton
Kim C. Mansky
Jennifer J. Westendorf
Elizabeth W. Bradley
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
description Abstract Previous studies examining the role of the histone deacetylase Hdac3 within myeloid cells demonstrated that Hdac3 promotes M2 activation and tissue healing in inflammatory conditions. Since myeloid lineage cells are required for proper bone formation and regeneration, in this study we examined the functions of Hdac3 during bone healing. Conditional deletion of Hdac3 within myeloid progenitors accelerates healing of cortical bone defects. Moreover, reduced osteoclast numbers within the defect site are correlated with Hdac3 suppression. Ex vivo osteoclastogenesis assays further demonstrate that Hdac3 deficiency limits osteoclastogenesis, the number of nuclei per cell and bone resorption, suggesting a defect in cell fusion. High throughput RNA sequencing identified the transmembrane protein Pmepa1 as a differentially expressed gene within osteoclast progenitor cells. Knockdown of Pmepa1 partially restores defects in osteoclastogenesis induced by Hdac3 deficiency. These results show that Hdac3 is required for optimal bone healing and osteoclast fusion, potentially via its regulation of Pmepa1 expression.
format article
author David H. H. Molstad
Elizabeth Zars
Andrew Norton
Kim C. Mansky
Jennifer J. Westendorf
Elizabeth W. Bradley
author_facet David H. H. Molstad
Elizabeth Zars
Andrew Norton
Kim C. Mansky
Jennifer J. Westendorf
Elizabeth W. Bradley
author_sort David H. H. Molstad
title Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
title_short Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
title_full Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
title_fullStr Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
title_full_unstemmed Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
title_sort hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via pmepa1
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/75c8d6bcd4f746f8a282c844bfc8dcbf
work_keys_str_mv AT davidhhmolstad hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1
AT elizabethzars hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1
AT andrewnorton hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1
AT kimcmansky hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1
AT jenniferjwestendorf hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1
AT elizabethwbradley hdac3deletioninmyeloidprogenitorcellsenhancesbonehealinginfemalesandlimitsosteoclastfusionviapmepa1
_version_ 1718395350261170176